<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Contemp Oncol (Pozn)</journal-id><journal-id journal-id-type="iso-abbrev">Contemp Oncol (Pozn)</journal-id><journal-id journal-id-type="publisher-id">WO</journal-id><journal-title-group><journal-title>Contemporary Oncology</journal-title></journal-title-group><issn pub-type="ppub">1428-2526</issn><issn pub-type="epub">1897-4309</issn><publisher><publisher-name>Termedia Publishing House</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27647993</article-id><article-id pub-id-type="pmc">5013690</article-id><article-id pub-id-type="publisher-id">28095</article-id><article-id pub-id-type="doi">10.5114/wo.2016.61570</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to Editor</subject></subj-group></article-categories><title-group><article-title>Microbiological spectrum of pneumonia in patients with lung cancer</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tamura</surname><given-names>Tomohiro</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Satoh</surname><given-names>Hiroaki</given-names></name></contrib></contrib-group><aff>Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, Tsukuba, Japan</aff><author-notes><corresp id="cor1"><bold>Address for correspondence: Hiroaki Satoh</bold> MD, PhD, Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, Miya-machi 3-2-7, Mito, Ibaraki, 310-0015, Japan. tel. +81-29-231-2371. e-mail: <email xlink:href="hirosato@md.tsukuba.ac.jp">hirosato@md.tsukuba.ac.jp</email></corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>8</month><year>2016</year></pub-date><pub-date pub-type="ppub"><year>2016</year></pub-date><volume>20</volume><issue>3</issue><fpage>266</fpage><lpage>266</lpage><history><date date-type="received"><day>15</day><month>5</month><year>2016</year></date><date date-type="accepted"><day>22</day><month>6</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2016 Termedia Sp. z o. o.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.</license-p></license></permissions></article-meta></front><body><p>We read with interest the article entitled &#x0201c;Retrospective analysis of the microbiological spectrum of pneumonia in Turkish patients with lung cancer&#x0201d; by Avci <italic>et al</italic>. (Contemporary Oncology 2016; 20: 63-66). We are surprised to read that the most frequent isolate from sputum of lung cancer patients with pneumonia was <italic>Aspergillus fumigatus</italic> [<xref rid="CIT0001" ref-type="bibr">1</xref>]. We do understand gram negative bacteria such as <italic>Haemophillus influenza</italic> and <italic>Pseudomonas aeruginosa</italic> cause pneumonia in lung cancer patients, but we do not encounter fungal pneumonia in lung cancer patients with usual platinum-based chemotherapy. With regards to the results, we do appreciate hearing from the authors whether lung cancer patients with <italic>Aspergillus fumigatus</italic> in their sputum had had antimicrobial chemotherapy frequently. For the most important concern, we do wonder whether <italic>Aspergillus fumigatus</italic> truly caused pneumonia, and whether the antifungal therapy was required for the fungal pneumonia. We do understand the most frequent isolate from sputum was <italic>Aspergillus fumigates</italic>, however, we do wonder whether it would cause pneumonia. Were there any possibilities of contamination or colonization? We would like to ask the authors what was the definition of &#x0201c;cause of pneumonia&#x0201d; from the bacteriological and clinical point of view.</p></body><back><ref-list><title>References</title><ref id="CIT0001"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avc&#x00131;</surname><given-names>N</given-names></name><name><surname>Hartavi</surname><given-names>M</given-names></name><name><surname>Ka&#x000e7;an</surname><given-names>T</given-names></name><etal/></person-group><article-title>Retrospective analysis of the microbiological spectrum of pneumonia in Turkish patients with lung cancer</article-title><source>Contemp Oncol (Pozn)</source><year>2016</year><volume>20</volume><fpage>63</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">27095942</pub-id></element-citation></ref></ref-list></back></article>